Human LIF Quantikine ELISA Kit DLF00B from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman LIF Quantikine ELISA Kit
CompanyR&D Systems, a Bio-Techne Brand
Price $680.00Supplier Page View Company Product Page
Catalog NumberDLF00B
Quantity1 Kit
ApplicationsELISA
Detection Range31.30 - 2000 pg/mL
ReactivityHuman
Sample TypeCell Culture Supernates (50 uL), Serum (50 uL), EDTA Plasma (50 uL), Heparin Plasma (50 uL)
Sensitivity5.36 pg/mL
Detection TargetLIF
Assay Time4.5 hours
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene NameLIF interleukin 6 family cytokine
NCBI Gene AliasesCDF, DIA, HILDA, MLPLI

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonizationThe FASEB JournalDecember 14, 2024Theressa Ewa, Neel Panchwagh, Chin‐Hsien Tai, Leela Rani Avula, Sarah Joseph, Michael W. Rudloff, Nargis Malik, Xianyu Zhang, Christine Alewineconcentrations were measured using Quantikine ELISA Kits (R&D Systems, for MSLN #DMSLN0, IL‐1α #DLA50, LIF #DLF00B). For assessment of MPF, streptavidin assay plates (Meso‐Scale Diagnostics, MSD, Rockville, MD) were

(2) Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosisEBioMedicineDecember 1, 2022Xu S, Yang X, Chen Q, Liu Z, Chen Y, Yao X, Xiao A, Tian J, Xie L, Zhou M, et al.

(3) Aptamer-SH2 superbinder-based targeted therapy for pancreatic ductal adenocarcinomaClinical and translational medicineMarch 1, 2021Liu AD, Zhou J, Bi XY, Hou GQ, Li SS, Chen Q, Xu H, Cao X.assay Leukemia Inhibitory factor (LIF) in PSC culture medium was evaluated by using a human LIF ELISA kit (DLF00B). LIF, IL6, and IL11 in mouse tissues or serum were measured by using mouse ELISA kits (MLF00, M6000B,

(4) MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS modelStem cell research & therapyJanuary 19, 2021Kaspi H, Semo J, Abramov N, Dekel C, Lindborg S, Kern R, Lebovits C, Aricha R.LIF concentrations were measured using Quantikine kits (R&D Systems, Minneapolis, MN; Cat# DAR001, DLF00B). HGF and TSG-6 concentration were measured with ELISA kits from RayBiotech, USA (Cat# ELH-HGF-CL-1,

(5) LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsiaReproduction (Cambridge, England)March 1, 2018Li H, Yao J, Chang X, Wu J, Duan T, Wang K.

(6) Leukemia inhibitory factor is dysregulated in the endometrium and uterine flushing fluid of patients with adenomyosis during implantation windowFertility and sterilityJune 1, 2010Xiao Y, Sun X, Yang X, Zhang J, Xue Q, Cai B, Zhou Y.

(7) The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromesLeukemia researchApril 1, 2010da Costa SV, Roela RA, Junqueira MS, Arantes C, Brentani MM.

(8) Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factorFASEB journal : official publication of the Federation of American Societies for Experimental BiologyJuly 1, 2009Evans J, Catalano RD, Brown P, Sherwin R, Critchley HO, Fazleabas AT, Jabbour HN.

(9) Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivoCancer researchJanuary 15, 2009Bronte-Tinkew DM, Terebiznik M, Franco A, Ang M, Ahn D, Mimuro H, Sasakawa C, Ropeleski MJ, Peek RM Jr, Jones NL.

(10) Isoflavones regulate secretion of leukemia inhibitory factor and transforming growth factor {beta} and expression of glycodelin in human endometrial epithelial cellsThe Journal of endocrinologyFebruary 1, 2008Xu JW, Yasui N, Ikeda K, Pan WJ, Watanabe J, Shiotani M, Yanaihara A, Miki T, Yamori Y.

(11) Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cellsBloodDecember 15, 2007Duluc D, Delneste Y, Tan F, Moles MP, Grimaud L, Lenoir J, Preisser L, Anegon I, Catala L, Ifrah N, et al.

(12) Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: Involvement of regulation of LIF and its receptor expressionInternational journal of oncologyApril 1, 2007Kamohara H, Ogawa M, Ishiko T, Sakamoto K, Baba H.

(13) Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formationThe Journal of neuroscience : the official journal of the Society for NeuroscienceNovember 22, 2006Zhang Y, Taveggia C, Melendez-Vasquez C, Einheber S, Raine CS, Salzer JL, Brosnan CF, John GR.

(14) Increased ENA-78 in the follicular fluid of patients with endometriosisActa obstetricia et gynecologica ScandinavicaJanuary 1, 2006Wunder DM, Mueller MD, Birkhäuser MH, Bersinger NA.

(15) Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failureHeart and vesselsSeptember 1, 2004Hirota H, Izumi M, Hamaguchi T, Sugiyama S, Murakami E, Kunisada K, Fujio Y, Oshima Y, Nakaoka Y, Yamauchi-Takihara K.

(16) Effect of azacytidine in the release of leukemia inhibitory factor, oncostatin m, interleukin (IL)-6, and IL-11 by mononuclear cells of patients with refractory anemiaCytokineNovember 24, 2002López-Karpovitch X, Barrales-Benítez O, Flores M, Piedras J.

(17) Role of mitogen-activated protein kinase family in serum-induced leukaemia inhibitory factor and interleukin-6 secretion by bone marrow stromal cellsBritish journal of pharmacologyAugust 1, 2002Nakao T, Kim S, Ohta K, Kawano H, Hino M, Miura K, Tatsumi N, Iwao H.

(18) The significance of cytokines, chemical composition, and murine embryo development in hydrosalpinx fluid for predicting the IVF outcome in women with hydrosalpinxHuman reproduction (Oxford, England)January 1, 2002Chen CD, Yang JH, Lin KC, Chao KH, Ho HN, Yang YS.

(19) Expression of interleukin-6, leukemia inhibitory factor and their receptors by colonic epithelium and pericryptal fibroblastsJournal of gastroenterology and hepatologySeptember 1, 2001Rockman SP, Demmler K, Roczo N, Cosgriff A, Phillips WA, Thomas RJ, Whitehead RH.

(20) Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase responseExperimental hematologyJuly 1, 2001Carstanjen D, Regenfus M, Müller C, Salama A.

Be the First to Write a Review!

LIF ELISA